Stocktoria
Enlivex Ltd. ENLV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-07-30
Chart by TradingView
3/9
Piotroski F — financial health
11.58
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$15.0M | -$15.9M | -$29.4M | -$25.8M | -$19.3M |
| Net income | $1.2B | -$15.0M | -$29.1M | -$31.1M | -$14.5M |
| Operating cash flow | -$10.4M | -$13.0M | -$23.5M | -$24.0M | -$17.5M |
| Free cash flow | -$10.5M | -$13.1M | -$23.8M | -$32.1M | -$19.2M |
| Total assets | $2.3B | $27.7M | $36.8M | $67.6M | $95.1M |
| Total liabilities | $392.1M | $4.1M | $6.7M | $10.8M | $10.1M |
| Shareholders' equity | $1.9B | $23.6M | $30.1M | $56.8M | $85.0M |
| Ratios | |||||
| Return on assets | 53.1% | -54.2% | -78.9% | -45.9% | -15.2% |
| Return on equity | 63.9% | -63.6% | -96.6% | -54.6% | -17.0% |
| Current ratio | 193.24 | 6.84 | 5.57 | 7.92 | 18.32 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 11.58 (safe)
- Working capital / assets 0.745
- Retained earnings / assets 0.476
- EBIT / assets -0.006
- Equity / liabilities 4.935
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001596812 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.